annb0t
Top 20
ResMed Inc. (NYSE:RMD) investors will be delighted, with the company turning in some strong numbers with its latest results. It was overall a positive result, with revenues beating expectations by 2.1% to hit US$1.2b. ResMed reported statutory earnings per share (EPS) US$2.04, which was a notable 15% above what the analysts had forecast. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the compan...
>>> Read more: ResMed Inc. Just Recorded A 15% EPS Beat: Here's What Analysts Are Forecasting Next
>>> Read more: ResMed Inc. Just Recorded A 15% EPS Beat: Here's What Analysts Are Forecasting Next
